# SCRG1

## Overview
SCRG1 (stimulator of chondrogenesis 1) is a gene that encodes a secreted protein involved in various cellular processes, particularly within mesenchymal stem cells (hMSCs). The SCRG1 protein is integral to maintaining the self-renewal, migration, and osteogenic differentiation potential of hMSCs, making it significant in regenerative medicine and bone-related therapies. It functions by interacting with the receptor BST1 and β1 integrin, activating key signaling pathways such as MEK/ERK and PI3K/Akt, which are essential for cellular migration and differentiation (Aomatsu2014Novel). Additionally, SCRG1 is implicated in immune response modulation and is upregulated in conditions like osteoarthritis, suggesting its potential as a biomarker and therapeutic target (Liu2022Identification). The protein's involvement in these pathways underscores its importance in both physiological and pathological contexts.

## Function
SCRG1 (stimulator of chondrogenesis 1) is a gene that encodes a protein involved in several key cellular processes, particularly in mesenchymal stem cells (hMSCs). In healthy human cells, SCRG1 plays a crucial role in maintaining the self-renewal, migration, and osteogenic differentiation potential of hMSCs. It is a secreted protein that stimulates signaling pathways such as ERK, JNK, and PI3K, which are essential for the migratory activity of these cells (Aomatsu2014Novel). SCRG1 interacts with its receptor BST1 to activate these pathways, thereby enhancing the migratory and self-renewal capabilities of hMSCs (Aomatsu2014Novel).

SCRG1 is also involved in preserving the osteogenic differentiation potential of hMSCs, even after extensive ex vivo expansion, which is vital for maintaining their therapeutic utility (Aomatsu2014Novel). The protein forms a complex with BST1 and β1 integrin, activating MEK/ERK and PI3K/Akt signaling pathways, which are crucial for maintaining the migratory activity of MSCs (Aomatsu2014Novel). Additionally, SCRG1 is implicated in chondrogenic differentiation, where it is regulated by the lncRNA ADAMTS9-AS2 through a competing endogenous RNA mechanism involving miR-942-5p (Huang2019lncRNA).

## Clinical Significance
The SCRG1 gene has been implicated in several clinical conditions due to its role in osteoarthritis (OA) and its expression in the central nervous system. In osteoarthritis, SCRG1 is significantly upregulated in synovitis, suggesting its involvement in immune response and inflammation. This upregulation indicates that SCRG1 may serve as a biomarker and therapeutic target for OA, with potential treatments including Valproic Acid (Liu2022Identification). The gene's expression is associated with pathways involved in immune regulation, such as the MAPK, PI3K-Akt, and NF-kB signaling pathways, which are crucial for OA progression (Liu2022Identification).

In the context of mesenchymal stem cells (hMSCs), SCRG1 is involved in maintaining the self-renewal and differentiation potential of these cells. Alterations in SCRG1 expression can impact the therapeutic potential of hMSCs in regenerative medicine, particularly in bone-related applications. The SCRG1/BST1 axis is crucial for preserving the osteogenic differentiation potential of hMSCs, which is important for clinical applications involving bone-forming cell therapy (Aomatsu2014Novel). Changes in SCRG1 interactions may also affect neurodegenerative conditions, given its expression in the central nervous system.

## Interactions
SCRG1 interacts with various proteins and signaling pathways, playing a significant role in cellular processes. In mesenchymal stem cells (MSCs), SCRG1 forms a complex with BST1 and β1 integrin, which activates the MEK/ERK and PI3K/Akt signaling pathways. This interaction is crucial for MSC migration and maintaining their osteogenic differentiation potential (Aomatsu2014Novel). The SCRG1/BST1 axis is also involved in preserving the expression of stem cell markers such as CD271/LNGFR and POU5F1, indicating its role in maintaining stem cell pluripotency (Aomatsu2014Novel).

In macrophage-like Raw264.7 cells, SCRG1 enhances the phosphorylation of ERK1/2, a key component of the MAPK signaling pathway, which is involved in regulating inflammatory responses. This interaction suppresses LPS-induced production of the chemokine CCL22, highlighting SCRG1's role in modulating immune responses through ERK1/2 signaling (Inoue2017SCRG1).

SCRG1 is also suggested to interact with miRNA hsa-miR-363-3p, indicating a potential regulatory role in osteoarthritis synovitis (Liu2022Identification). Despite limited current research on its interactions, SCRG1 is proposed to form complexes with other proteins, such as LY68, to perform its functions (Liu2022Identification).


## References


[1. (Huang2019lncRNA) Ming-Jian Huang, Jing-Yu Zhao, Jia-Jia Xu, Jing Li, Yi-Fu Zhuang, and Xiao-Ling Zhang. Lncrna adamts9-as2 controls human mesenchymal stem cell chondrogenic differentiation and functions as a cerna. Molecular Therapy - Nucleic Acids, 18:533–545, December 2019. URL: http://dx.doi.org/10.1016/j.omtn.2019.08.027, doi:10.1016/j.omtn.2019.08.027. This article has 32 citations.](https://doi.org/10.1016/j.omtn.2019.08.027)

[2. (Liu2022Identification) Guoqiang Liu, Guisong He, Jie Zhang, Zhongmin Zhang, and Liang Wang. Identification of scrg1 as a potential therapeutic target for human synovial inflammation. Frontiers in Immunology, May 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.893301, doi:10.3389/fimmu.2022.893301. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.893301)

[3. (Aomatsu2014Novel) Emiko Aomatsu, Noriko Takahashi, Shunsuke Sawada, Naoto Okubo, Tomokazu Hasegawa, Masayuki Taira, Hiroyuki Miura, Akira Ishisaki, and Naoyuki Chosa. Novel scrg1/bst1 axis regulates self-renewal, migration and osteogenic differentiation potential in mesenchymal stem cells. Scientific Reports, January 2014. URL: http://dx.doi.org/10.1038/srep03652, doi:10.1038/srep03652. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep03652)

[4. (Inoue2017SCRG1) Manabu Inoue, Junko Yamada, Emiko Aomatsu-Kikuchi, Kazuro Satoh, Hisatomo Kondo, Akira Ishisaki, and Naoyuki Chosa. Scrg1 suppresses lps-induced ccl22 production through erk1/2 activation in mouse macrophage raw264.7 cells. Molecular Medicine Reports, 15(6):4069–4076, April 2017. URL: http://dx.doi.org/10.3892/mmr.2017.6492, doi:10.3892/mmr.2017.6492. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.3892/mmr.2017.6492)